| 臺大學術典藏 |
2021-08-23T03:20:27Z |
Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer
|
CHUNG-YU CHEN; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-23T03:20:27Z |
Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment
|
Wang P.-H.; Pan S.-W.; Shu C.-C.; CHUNG-YU CHEN; Wei Y.-F.; Cheng S.-L.; Wang H.-C.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-23T02:42:25Z |
Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit
|
Hsiue E.H.-C.; Lee P.-L.; YUNG-HSUAN CHEN; Wu T.-H.; Cheng C.-F.; Cheng K.-M.; Yang P.-C.; Chen H.-W.; Lin P.-Y.; Chiang D.-L.; Wu H.-D.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-23T02:42:25Z |
Miliary pulmonary nodules: An unusual presentation of leptospirosis
|
YUNG-HSUAN CHEN; Yang C.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-23T02:42:24Z |
Author reply to Letter to Editor “Weaning outcome of solid cancer patients requiring mechanical ventilation in the ICU: Other factors to explore”
|
Hsiue E.H.-C.; Lee P.-L.; YUNG-HSUAN CHEN; Yu C.-J. |
| 臺大學術典藏 |
2021-08-23T02:42:24Z |
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study
|
YUNG-HSUAN CHEN; Chen Y.-F.; Chen C.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:50:14Z |
Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012
|
Lee M.-R.; Wang H.-C.; Yang C.-Y.; Lin C.-K.; HAN-YUEH KUO; Ko J.-C.; Sheng W.-H.; Lee L.-N.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-20T08:00:42Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
BIN-CHI LIAO; Lee J.-H.; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-20T08:00:42Z |
151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs
|
BIN-CHI LIAO; Bai Y.-Y.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang J. |
| 臺大學術典藏 |
2021-08-20T08:00:40Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
BIN-CHI LIAO; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2021-08-20T08:00:40Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; BIN-CHI LIAO; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:39Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; BIN-CHI LIAO; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-20T06:57:46Z |
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
|
Huang T.T.-M.; Chien Y.-C.; Wang C.-H.; Chang S.-Y.; JANN-TAY WANG; Hsieh S.-C.; Yeh Y.-C.; Ku S.-C.; Yu C.-J.; Chiang B.-L.; Chang S.-C.; Tolwani A. |
| 臺大學術典藏 |
2021-08-20T04:24:47Z |
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
|
Huang T.T.-M.; Chien Y.-C.; Wang C.-H.; Chang S.-Y.; Wang J.-T.; Hsieh S.-C.; Yeh Y.-C.; Ku S.-C.; Yu C.-J.; Chiang B.-L.; SHAN-CHWEN CHANG; Tolwani A. |
| 臺大學術典藏 |
2021-08-16T08:36:29Z |
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates
|
Lee M.-R.; ARISTINE CHENG; Lee Y.-C.; Yang C.-Y.; Lai C.-C.; Huang Y.-T.; Ho C.-C.; Wang H.-C.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-16T08:36:27Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
Lee M.-R.; ARISTINE CHENG; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; Liang S.-K.; Liao C.-H.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-16T08:36:23Z |
Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis
|
Chung K.-P.; Chang H.-T.; Lo S.-C.; Chang L.-Y.; Lin S.-Y.; ARISTINE CHENG; Huang Y.-T.; Chen C.-C.; Lee M.-R.; Chen Y.-J.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; Ho C.-C.; Huang M.-T.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-08-16T03:26:38Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; I-CHUN CHEN; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-11T06:55:46Z |
Clinical features and outcome of sporadic serogroup W135 disease Taiwan
|
Wang J.-L.; DING-PING LIU; Yen J.-J.; Yu C.-J.; Liu H.-C.; Lin C.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-11T03:46:53Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; ZHONG-ZHE LIN; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C. |
| 臺大學術典藏 |
2021-08-11T03:46:53Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-08-11T03:46:52Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y. |
| 臺大學術典藏 |
2021-08-11T03:46:51Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; ZHONG-ZHE LIN; Yu C.-J.; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2021-08-11T03:46:50Z |
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors
|
Lin C.-C.; Hsu H.-H.; Sun C.-T.; Shih J.-Y.; ZHONG-ZHE LIN; Yu C.-J.; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; Yang C.-H.; Mok T. |
| 臺大學術典藏 |
2021-08-11T03:46:38Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; ZHONG-ZHE LIN; Lin C.-C.; Yang J.C.H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-11T03:46:37Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients
|
Yao Z.-H.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; ZHONG-ZHE LIN; Lin C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-11T03:46:37Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; ZHONG-ZHE LIN; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-11T03:46:35Z |
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life
|
Hsieh C.-C.; Ho C.-C.; ZHONG-ZHE LIN; Yu C.-J.; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H. |
| 臺大學術典藏 |
2021-08-11T03:46:34Z |
The Short- and Long-term Causal Relationships Between Self-compassion, Trait Mindfulness, Caregiver Stress, and Depressive Symptoms in Family Caregivers of Patients with Lung Cancer
|
Hsieh C.-C.; ZHONG-ZHE LIN; Ho C.-C.; Yu C.-J.; Chen H.-J.; Chen Y.-W.; Hsiao F.-H. |
| 臺大學術典藏 |
2021-08-11T03:46:34Z |
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
|
Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; ZHONG-ZHE LIN; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-05T02:41:48Z |
Dynamic dispatching for re-entrant production lines - A deep learning approach
|
Zhou F.-Y;Wu C.-H;Yu C.-J.; Zhou F.-Y; Wu C.-H; Yu C.-J.; CHENG-HUNG WU |
| 臺大學術典藏 |
2021-07-13T06:04:41Z |
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer
|
LEE JIH-HSIANG; Yu C.-J.; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:40Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; LEE JIH-HSIANG; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:37Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
LEE JIH-HSIANG; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:36Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao B.-C.; LEE JIH-HSIANG; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; LEE JIH-HSIANG; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:32Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:32Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao B.-C.; Bai Y.-Y.; LEE JIH-HSIANG; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2021-07-13T06:04:31Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; LEE JIH-HSIANG; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:30Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-13T06:04:30Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
LEE JIH-HSIANG; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-07T03:41:26Z |
Prevention of elastase-induced emphysema in placenta growth factor knock-out mice
|
Cheng S.L.; Wang H.C.; Yu C.J.; Tsao P.N.; Carmeliet P.; SHIH-JUNG CHENG; Yang P.C. |
| 臺大學術典藏 |
2021-07-07T03:41:24Z |
Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy
|
Cheng S.-L.; Wang H.-C.; SHIH-JUNG CHENG; Yu C.-J. |
| 臺大學術典藏 |
2021-07-06T08:15:30Z |
Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
|
Liu H.-W.; ALEX YUNN-JY CHEN; Lai Y.-C.; Huang C.-Y.; Huang Y.-L.; Lin M.-T.; Han S.-Y.; Chen C.-L.; Yu C.-J.; Lee P.-L. |
| 臺大學術典藏 |
2021-07-05T05:42:00Z |
Elastase induces lung epithelial cell autophagy through placental growth factor A new insight of emphysema pathogenesis
|
Hou H.-H.; Cheng S.-L.; Chung K.-P.; YEN-PING KUO; Yeh C.-C.; Chang B.-E.; Lu H.-H.; Wang H.-C.; Yu C.-J. |
| 臺大學術典藏 |
2021-07-02T07:27:58Z |
Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus
|
Yu C.-J.; Chen Y.-C.; Hsiao C.-H.; Kuo T.-C.; Chang S.C.; Lu C.-Y.; Wei W.-C.; Lee C.-H.; Huang L.-M.; Chang M.-F.; Ho H.-N.; Fang-Jen Scott Lee |
